RNAC logo

Cartesian Therapeutics (RNAC) Selling, General & Administrative Expenses

Annual SGA

$40.58 M
+$16.72 M+70.07%

December 31, 2023

Summary

Performance

1-Year Change

+70.07%

3-Year Change

+114.57%

5-Year Change

+122.51%

15-Year Change

+115.56%

RNAC SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

57.37%
RNAC annual SGA is higher than 57.37% of companies in Healthcare sector

High & Low

All-time High

$40.58 M
RNAC annual SGA is currently at an all-time high

3-Year Low

$20.94 M
RNAC annual SGA is currently +93.82% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
RNAC previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 7, 2025
RNAC next annual earnings announcement is scheduled for Mar 7, 2025

OtherRNACexpensesmetrics:

Annual Total Expenses

$112.42 M
RNAC annual total expenses is $112.42 million

Annual Operating Expenses

$112.42 M
RNAC annual total operating expenses is $112.42 million

Annual Cost Of Goods Sold

-
RNAC annual cost of goods sold value is unknown

Annual Interest Expense

$2.83 M
RNAC annual interest expense is $2.83 million

Quarterly SGA

$6.56 M
-$465.00 K-6.62%

September 1, 2024

Summary

Performance

3-Month Change

-6.62%

1-Year Change

-30.56%

3-Year Change

+3.76%

5-Year Change

+3.76%

RNAC Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.75%
RNAC quarterly SGA is higher than 44.75% of companies in Healthcare sector

High & Low

All-time High

$22.17 M
RNAC quarterly SGA is currently -70.40% below its historical high of $22.17 million

3-Year Low

$5.54 M
RNAC quarterly SGA is currently +18.51% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
RNAC previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
RNAC next earnings announcement is scheduled for Mar 7, 2025

OtherRNACexpensesmetrics:

Quarterly Total Expenses

$17.96 M
RNAC quarterly total expenses is $17.96 million

Quarterly Operating Expenses

$17.96 M
RNAC quarterly total operating expenses is $17.96 million

Quarterly Cost Of Goods Sold

-
RNAC quarterly cost of goods sold value is unknown

Quarterly Interest Expense

$0.00
RNAC quarterly interest expense is $0.00

TTM SGA

-$2.63 B
-$244.83 M-10.28%

September 1, 2024

Summary

Performance

3-Month Change

-5901.34%

1-Year Change

-6021.98%

3-Year Change

-11103.15%

5-Year Change

-11103.15%

RNAC TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

17.45%
RNAC TTM SGA is higher than 17.45% of companies in Healthcare sector

High & Low

All-time High

-$111.51 M

3-Year Low

-$2.63 B
RNAC TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
RNAC previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
RNAC next earnings announcement is scheduled for Mar 7, 2025

OtherRNACexpensesmetrics:

Annual Total Expenses

$112.42 M
RNAC annual total expenses is $112.42 million

Annual Operating Expenses

$112.42 M
RNAC annual total operating expenses is $112.42 million

TTM Cost Of Goods Sold

-
RNAC TTM cost of goods sold value is unknown

TTM Interest Expense

$0.00
RNAC TTM interest expense is $0.00

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$40.58 M
RNAC annual SGA is $40.58 million

Annual Operating Expenses

$112.42 M
RNAC annual total operating expenses is $112.42 million

Annual Cost Of Goods Sold

-
RNAC annual cost of goods sold value is unknown

RNAC Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+70.1%-30.6%-6022.0%
3 y3 years+114.6%+3.8%-10000.0%
5 y5 years+122.5%+3.8%-10000.0%

RNAC Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+93.8%-70.4%+18.5%-65.1%at low
5 y5-yearat high+147.6%-70.4%+61.1%-108.7%at low
alltimeall timeat high+410.3%-70.4%+250.5%-2254.6%at low

Cartesian Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$6.56 M(-6.6%)
$45.21 M(-0.1%)
Jun 2024
-
$7.03 M(-25.6%)
$45.26 M(+2.1%)
Mar 2024
-
$9.45 M(-57.4%)
$44.34 M(+9.3%)
Dec 2023
$40.58 M(+70.1%)
$22.17 M(+235.2%)
$40.58 M(+64.0%)
Sep 2023
-
$6.61 M(+8.3%)
$24.74 M(+3.5%)
Jun 2023
-
$6.11 M(+7.2%)
$23.89 M(-0.5%)
Mar 2023
-
$5.70 M(-9.9%)
$24.02 M(+0.7%)
Dec 2022
$23.86 M(+14.0%)
-
-
Dec 2022
-
$6.32 M(+9.6%)
$23.86 M(+3.4%)
Sep 2022
-
$5.77 M(-7.4%)
$23.08 M(+1.4%)
Jun 2022
-
$6.23 M(+12.5%)
$22.75 M(+7.0%)
Mar 2022
-
$5.54 M(-0.1%)
$21.27 M(+1.6%)
Dec 2021
$20.94 M(+10.7%)
$5.54 M(+1.8%)
$20.94 M(+3.9%)
Sep 2021
-
$5.45 M(+14.7%)
$20.16 M(+5.4%)
Jun 2021
-
$4.75 M(-8.8%)
$19.13 M(-4.4%)
Mar 2021
-
$5.20 M(+9.4%)
$20.02 M(+5.8%)
Dec 2020
$18.91 M(+15.4%)
$4.76 M(+7.6%)
$18.91 M(+3.8%)
Sep 2020
-
$4.42 M(-21.6%)
$18.23 M(+4.2%)
Jun 2020
-
$5.64 M(+37.6%)
$17.50 M(+9.5%)
Mar 2020
-
$4.10 M(+0.6%)
$15.97 M(-2.5%)
DateAnnualQuarterlyTTM
Dec 2019
$16.39 M(-10.1%)
$4.07 M(+10.4%)
$16.39 M(-6.2%)
Sep 2019
-
$3.69 M(-10.3%)
$17.46 M(-2.1%)
Jun 2019
-
$4.11 M(-8.8%)
$17.83 M(-1.4%)
Mar 2019
-
$4.51 M(-12.3%)
$18.08 M(-0.9%)
Dec 2018
$18.24 M(-3.1%)
$5.15 M(+26.9%)
$18.24 M(-2.8%)
Sep 2018
-
$4.06 M(-7.0%)
$18.76 M(-1.7%)
Jun 2018
-
$4.36 M(-6.7%)
$19.08 M(-2.8%)
Mar 2018
-
$4.67 M(-17.6%)
$19.63 M(+4.2%)
Dec 2017
$18.83 M(+44.2%)
$5.67 M(+29.6%)
$18.83 M(-0.5%)
Sep 2017
-
$4.38 M(-10.7%)
$18.91 M(+11.1%)
Jun 2017
-
$4.90 M(+26.5%)
$17.03 M(+17.1%)
Mar 2017
-
$3.88 M(-32.7%)
$14.54 M(+11.4%)
Dec 2016
$13.05 M(+56.6%)
$5.76 M(+130.7%)
$13.05 M(+40.0%)
Sep 2016
-
$2.50 M(+3.2%)
$9.32 M(+3.3%)
Jun 2016
-
$2.42 M(+1.6%)
$9.02 M(+2.0%)
Mar 2016
-
$2.38 M(+17.3%)
$8.84 M(+6.1%)
Dec 2015
$8.34 M(+4.8%)
$2.03 M(-7.5%)
$8.34 M(+32.2%)
Sep 2015
-
$2.19 M(-1.9%)
$6.30 M(+53.4%)
Jun 2015
-
$2.24 M(+19.6%)
$4.11 M(+119.6%)
Mar 2015
-
$1.87 M
$1.87 M
Dec 2014
$7.95 M
-
-

FAQ

  • What is Cartesian Therapeutics annual SGA?
  • What is the all time high annual SGA for Cartesian Therapeutics?
  • What is Cartesian Therapeutics annual SGA year-on-year change?
  • What is Cartesian Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Cartesian Therapeutics?
  • What is Cartesian Therapeutics quarterly SGA year-on-year change?
  • What is Cartesian Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Cartesian Therapeutics?
  • What is Cartesian Therapeutics TTM SGA year-on-year change?

What is Cartesian Therapeutics annual SGA?

The current annual SGA of RNAC is $40.58 M

What is the all time high annual SGA for Cartesian Therapeutics?

Cartesian Therapeutics all-time high annual SGA is $40.58 M

What is Cartesian Therapeutics annual SGA year-on-year change?

Over the past year, RNAC annual SGA has changed by +$16.72 M (+70.07%)

What is Cartesian Therapeutics quarterly SGA?

The current quarterly SGA of RNAC is $6.56 M

What is the all time high quarterly SGA for Cartesian Therapeutics?

Cartesian Therapeutics all-time high quarterly SGA is $22.17 M

What is Cartesian Therapeutics quarterly SGA year-on-year change?

Over the past year, RNAC quarterly SGA has changed by -$2.89 M (-30.56%)

What is Cartesian Therapeutics TTM SGA?

The current TTM SGA of RNAC is -$2.63 B

What is the all time high TTM SGA for Cartesian Therapeutics?

Cartesian Therapeutics all-time high TTM SGA is -$111.51 M

What is Cartesian Therapeutics TTM SGA year-on-year change?

Over the past year, RNAC TTM SGA has changed by -$2.67 B (-6021.98%)